Metastatic disease and correlation with TNM stage in patients with sebaceous carcinoma
| Patient | TNM stage | Tumour size (mm) | Time to regional nodal metastases (months) | Time to distant metastases (months) | Treatment of metastases | Condition at last follow-up (follow-up months after treatment for metastases) |
|---|---|---|---|---|---|---|
| 1 | T2aN0M0 | 5 | 28 | – | Lymphadenectomy | Alive and well (19) |
| 2 | T2aN0M0 | 7 | 28 | – | Lymphadenectomy | Alive and well (22) |
| 3 | T2bN0M0 | 14 | 25 | – | Radiotherapy | Alive with disease (1) |
| 4 | T2bN1M0 | 10 | 0 (at presentation) | – | Lymphadenectomy | Alive and well (43) |
| 5 | T3bN1M1 | 20 | 0 (at presentation) | 0 (at presentation) | Radiotherapy | Died due to metastatic disease (31) |